BlackRock’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2M | Sell |
8,668,527
-274,538
| -3% | -$988K | ﹤0.01% | 2723 |
|
|
2025
Q1 | $26.7M | Sell |
8,943,065
-119,116
| -1% | -$356K | ﹤0.01% | 2735 |
|
|
2024
Q4 | $30.4M | Buy |
9,062,181
+71,447
| +0.8% | +$239K | ﹤0.01% | 2742 |
|
|
2024
Q3 | $30.1M | Sell |
8,990,734
-129,829
| -1% | -$435K | ﹤0.01% | 2743 |
|
|
2024
Q2 | $30.2M | Sell |
9,120,563
-122,743
| -1% | -$406K | ﹤0.01% | 2690 |
|
|
2024
Q1 | $37.3M | Sell |
9,243,306
-200,581
| -2% | -$810K | ﹤0.01% | 2574 |
|
|
2023
Q4 | $28.8M | Buy |
9,443,887
+1,252,385
| +15% | +$3.82M | ﹤0.01% | 2752 |
|
|
2023
Q3 | $24.6M | Buy |
8,191,502
+482,789
| +6% | +$1.45M | ﹤0.01% | 2780 |
|
|
2023
Q2 | $28.8M | Sell |
7,708,713
-333,023
| -4% | -$1.25M | ﹤0.01% | 2745 |
|
|
2023
Q1 | $26.9M | Buy |
8,041,736
+8,164
| +0.1% | +$27.3K | ﹤0.01% | 2767 |
|
|
2022
Q4 | $38.6M | Buy |
8,033,572
+162,451
| +2% | +$781K | ﹤0.01% | 2609 |
|
|
2022
Q3 | $44.8M | Buy |
7,871,121
+463,579
| +6% | +$2.64M | ﹤0.01% | 2497 |
|
|
2022
Q2 | $52.6M | Buy |
7,407,542
+782,849
| +12% | +$5.56M | ﹤0.01% | 2428 |
|
|
2022
Q1 | $47.8M | Buy |
6,624,693
+843,496
| +15% | +$6.09M | ﹤0.01% | 2579 |
|
|
2021
Q4 | $51.7M | Buy |
5,781,197
+1,644,396
| +40% | +$14.7M | ﹤0.01% | 2609 |
|
|
2021
Q3 | $145M | Buy |
4,136,801
+645,838
| +19% | +$22.6M | ﹤0.01% | 1941 |
|
|
2021
Q2 | $75M | Buy |
3,490,963
+2,415,459
| +225% | +$51.9M | ﹤0.01% | 2409 |
|
|
2021
Q1 | $66.4M | Sell |
1,075,504
-240,326
| -18% | -$14.8M | ﹤0.01% | 2409 |
|
|
2020
Q4 | $55M | Buy |
+1,315,830
| New | +$55M | ﹤0.01% | 2368 |
|